Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

Qing Xu, Jon Briggs, Sungman Park, Guilian Niu, Marcin Kortylewski, Shumin Zhang, Tanya Gritsko, James Turkson, Heidi Kay, Gregg L Semenza, Jin Q. Cheng, Richard Jove, Hua Yu

Research output: Contribution to journalArticle

Abstract

Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex challenge. While VEGF inducers abound, only two major transcription activators have been identified for its promoter: hypoxia inducible factor-1 (HIF-1) and signal transducer and activator of transcription (Stat3). Both HIF-1 expression and Stat3 activity are upregulated in diverse cancers. Here, we provide evidence that Stat3 is required for both basal and growth signal-induced expression of HIF-1. Moreover, induction of VEGF by diverse oncogenic growth stimuli, including IL-6R, c-Src, Her2/Neu, is attenuated in cells without Stat3 signaling. We further demonstrate that Stat3 regulates expression of Akt, which is required for growth signal-induced HIF-1 upregulation. Targeting Stat3 with a small-molecule inhibitor blocks HIF-1 and VEGF expression in vitro and inhibits tumor growth and angiogenesis in vivo. Furthermore, tumor cells' in vivo angiogenic capacity induced by IL-6R, which simultaneously activates Jak/STAT and PI3K/Akt pathways, is abrogated when Stat3 is inhibited. Activation of Stat3 signaling by various growth signaling is prevalent in diverse cancers. Results presented here demonstrate that Stat3 is an effective target for inhibiting tumor VEGF expression and angiogenesis.

Original languageEnglish (US)
Pages (from-to)5552-5560
Number of pages9
JournalOncogene
Volume24
Issue number36
DOIs
StatePublished - Aug 25 2005

Fingerprint

Hypoxia-Inducible Factor 1
Vascular Endothelial Growth Factor A
Growth
Neoplasms
Up-Regulation
Transducers
Phosphatidylinositol 3-Kinases
Proteins

Keywords

  • Akt
  • Angiogenesis
  • HIF-1
  • Stat3
  • VEGF

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., ... Yu, H. (2005). Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene, 24(36), 5552-5560. https://doi.org/10.1038/sj.onc.1208719

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. / Xu, Qing; Briggs, Jon; Park, Sungman; Niu, Guilian; Kortylewski, Marcin; Zhang, Shumin; Gritsko, Tanya; Turkson, James; Kay, Heidi; Semenza, Gregg L; Cheng, Jin Q.; Jove, Richard; Yu, Hua.

In: Oncogene, Vol. 24, No. 36, 25.08.2005, p. 5552-5560.

Research output: Contribution to journalArticle

Xu, Q, Briggs, J, Park, S, Niu, G, Kortylewski, M, Zhang, S, Gritsko, T, Turkson, J, Kay, H, Semenza, GL, Cheng, JQ, Jove, R & Yu, H 2005, 'Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways', Oncogene, vol. 24, no. 36, pp. 5552-5560. https://doi.org/10.1038/sj.onc.1208719
Xu, Qing ; Briggs, Jon ; Park, Sungman ; Niu, Guilian ; Kortylewski, Marcin ; Zhang, Shumin ; Gritsko, Tanya ; Turkson, James ; Kay, Heidi ; Semenza, Gregg L ; Cheng, Jin Q. ; Jove, Richard ; Yu, Hua. / Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. In: Oncogene. 2005 ; Vol. 24, No. 36. pp. 5552-5560.
@article{83662c8f71414256856796365435b711,
title = "Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways",
abstract = "Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex challenge. While VEGF inducers abound, only two major transcription activators have been identified for its promoter: hypoxia inducible factor-1 (HIF-1) and signal transducer and activator of transcription (Stat3). Both HIF-1 expression and Stat3 activity are upregulated in diverse cancers. Here, we provide evidence that Stat3 is required for both basal and growth signal-induced expression of HIF-1. Moreover, induction of VEGF by diverse oncogenic growth stimuli, including IL-6R, c-Src, Her2/Neu, is attenuated in cells without Stat3 signaling. We further demonstrate that Stat3 regulates expression of Akt, which is required for growth signal-induced HIF-1 upregulation. Targeting Stat3 with a small-molecule inhibitor blocks HIF-1 and VEGF expression in vitro and inhibits tumor growth and angiogenesis in vivo. Furthermore, tumor cells' in vivo angiogenic capacity induced by IL-6R, which simultaneously activates Jak/STAT and PI3K/Akt pathways, is abrogated when Stat3 is inhibited. Activation of Stat3 signaling by various growth signaling is prevalent in diverse cancers. Results presented here demonstrate that Stat3 is an effective target for inhibiting tumor VEGF expression and angiogenesis.",
keywords = "Akt, Angiogenesis, HIF-1, Stat3, VEGF",
author = "Qing Xu and Jon Briggs and Sungman Park and Guilian Niu and Marcin Kortylewski and Shumin Zhang and Tanya Gritsko and James Turkson and Heidi Kay and Semenza, {Gregg L} and Cheng, {Jin Q.} and Richard Jove and Hua Yu",
year = "2005",
month = "8",
day = "25",
doi = "10.1038/sj.onc.1208719",
language = "English (US)",
volume = "24",
pages = "5552--5560",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "36",

}

TY - JOUR

T1 - Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

AU - Xu, Qing

AU - Briggs, Jon

AU - Park, Sungman

AU - Niu, Guilian

AU - Kortylewski, Marcin

AU - Zhang, Shumin

AU - Gritsko, Tanya

AU - Turkson, James

AU - Kay, Heidi

AU - Semenza, Gregg L

AU - Cheng, Jin Q.

AU - Jove, Richard

AU - Yu, Hua

PY - 2005/8/25

Y1 - 2005/8/25

N2 - Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex challenge. While VEGF inducers abound, only two major transcription activators have been identified for its promoter: hypoxia inducible factor-1 (HIF-1) and signal transducer and activator of transcription (Stat3). Both HIF-1 expression and Stat3 activity are upregulated in diverse cancers. Here, we provide evidence that Stat3 is required for both basal and growth signal-induced expression of HIF-1. Moreover, induction of VEGF by diverse oncogenic growth stimuli, including IL-6R, c-Src, Her2/Neu, is attenuated in cells without Stat3 signaling. We further demonstrate that Stat3 regulates expression of Akt, which is required for growth signal-induced HIF-1 upregulation. Targeting Stat3 with a small-molecule inhibitor blocks HIF-1 and VEGF expression in vitro and inhibits tumor growth and angiogenesis in vivo. Furthermore, tumor cells' in vivo angiogenic capacity induced by IL-6R, which simultaneously activates Jak/STAT and PI3K/Akt pathways, is abrogated when Stat3 is inhibited. Activation of Stat3 signaling by various growth signaling is prevalent in diverse cancers. Results presented here demonstrate that Stat3 is an effective target for inhibiting tumor VEGF expression and angiogenesis.

AB - Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex challenge. While VEGF inducers abound, only two major transcription activators have been identified for its promoter: hypoxia inducible factor-1 (HIF-1) and signal transducer and activator of transcription (Stat3). Both HIF-1 expression and Stat3 activity are upregulated in diverse cancers. Here, we provide evidence that Stat3 is required for both basal and growth signal-induced expression of HIF-1. Moreover, induction of VEGF by diverse oncogenic growth stimuli, including IL-6R, c-Src, Her2/Neu, is attenuated in cells without Stat3 signaling. We further demonstrate that Stat3 regulates expression of Akt, which is required for growth signal-induced HIF-1 upregulation. Targeting Stat3 with a small-molecule inhibitor blocks HIF-1 and VEGF expression in vitro and inhibits tumor growth and angiogenesis in vivo. Furthermore, tumor cells' in vivo angiogenic capacity induced by IL-6R, which simultaneously activates Jak/STAT and PI3K/Akt pathways, is abrogated when Stat3 is inhibited. Activation of Stat3 signaling by various growth signaling is prevalent in diverse cancers. Results presented here demonstrate that Stat3 is an effective target for inhibiting tumor VEGF expression and angiogenesis.

KW - Akt

KW - Angiogenesis

KW - HIF-1

KW - Stat3

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=24644457736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644457736&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208719

DO - 10.1038/sj.onc.1208719

M3 - Article

VL - 24

SP - 5552

EP - 5560

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 36

ER -